BrightSpring Health Services, Inc. (BTSG)
| Market Cap | 11.92B +134.1% |
| Revenue (ttm) | 14.37B +26.4% |
| Net Income | 365.97M +458.6% |
| EPS | 1.64 +400.0% |
| Shares Out | 208.32M |
| PE Ratio | 34.94 |
| Forward PE | 28.30 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,601,833 |
| Open | 59.55 |
| Previous Close | 59.49 |
| Day's Range | 56.43 - 60.18 |
| 52-Week Range | 22.86 - 73.75 |
| Beta | 1.88 |
| Analysts | Strong Buy |
| Price Target | 78.94 (+37.94%) |
| Earnings Date | Jul 31, 2026 |
About BTSG
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for BTSG stock is "Strong Buy." The 12-month stock price target is $78.94, which is an increase of 37.94% from the latest price.
News
BrightSpring Health price target raised to $70 from $60 at Deutsche Bank
Deutsche Bank raised the firm’s price target on BrightSpring Health (BTSG) to $70 from $60 and keeps a Buy rating on the shares.
BrightSpring Health selloff appears overdone, says Mizuho
Mizuho reiterated an Outperform rating and $86 price target on BrightSpring Health (BTSG), noting the stock is down sharply following Q2 results as investors focus on gross margin performance within…
BrightSpring Health Services Earnings Call Transcript: Q2 2026
Q2 2026 saw 23% revenue growth and 44% adjusted EBITDA growth, driven by strong performance in both Pharmacy Solutions and Provider Services. Guidance for 2026 was raised, with continued investments in technology, M&A, and operational efficiency, despite IRA headwinds.
BrightSpring Health Services Earnings release: Q2 2026
BrightSpring Health Services released its Q2 2026 earnings on July 31, 2026, summarizing the period's financial results.
BrightSpring Health Services Slides: Q2 2026
BrightSpring Health Services has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 31, 2026.
BrightSpring Health Services Quarterly report: Q2 2026
BrightSpring Health Services has published its Q2 2026 quarterly earnings report on July 31, 2026.
BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services f...
BrightSpring Health to replace Chart Industries in S&P 400 at open on 7/17
17:18 EDT BrightSpring Health (BTSG) to replace Chart Industries (GTLS) in S&P 400 at open on 7/17
BrightSpring Health price target raised to $80 from $71 at Morgan Stanley
Morgan Stanley raised the firm’s price target on BrightSpring Health (BTSG) to $80 from $71 and keeps an Overweight rating on the shares. BrightSpring continues to execute well, with expectations…
BrightSpring Health price target raised to $80 from $60 at KeyBanc
KeyBanc raised the firm’s price target on BrightSpring Health (BTSG) to $80 from $60 and keeps an Overweight rating on the shares. Healthcare utilization continued to moderate through the first…
BrightSpring Health price target raised to $78 from $61 at Wells Fargo
Wells Fargo analyst Stephen Baxter raised the firm’s price target on BrightSpring Health (BTSG) to $78 from $61 and keeps an Overweight rating on the shares. The firm’s outlook for…
Guggenheim starts ‘well positioned’ BrightSpring Health with a Buy
As previously reported, Guggenheim initiated coverage of BrightSpring Health (BTSG) with a Buy rating and $81 price target BrightSpring is well positioned to capitalize on secular tailwinds in healthc...
BrightSpring Health initiated with a Buy at Guggenheim
Guggenheim initiated coverage of BrightSpring Health (BTSG) with a Buy rating and $81 price target
BrightSpring Health initiated with an Outperform at Raymond James
Raymond James analyst Parker Snure initiated coverage of BrightSpring Health (BTSG) with an Outperform rating and $80 price target
Raymond James starts BrightSpring Health at Outperform on ‘durable growth’
Raymond James initiated coverage of BrightSpring Health (BTSG) with an Outperform rating and $80 price target The firm sees the stock as a durable growth story with potential upside to…
BrightSpring Health Services, Inc. to Announce Second Quarter 2026 Financial Results on July 31, 2026
LOUISVILLE, Ky., July 08, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2026 ...
BrightSpring Health price target raised to $85 from $63 at UBS
UBS raised the firm’s price target on BrightSpring Health (BTSG) to $85 from $63 and keeps a Buy rating on the shares.
BrightSpring Health price target raised to $77 from $66 at BofA
BofA raised the firm’s price target on BrightSpring Health (BTSG) to $77 from $66 and keeps a Buy rating on the shares. The proposed 2027 Medicare rate update for home…
BrightSpring Health price target raised to $90 from $65 at BTIG
BTIG analyst David Larsen raised the firm’s price target on BrightSpring Health (BTSG) to $90 from $65 and keeps a Buy rating on the shares following management comments at recent…
BrightSpring Health price target raised to $81 from $65 at TD Cowen
TD Cowen raised the firm’s price target on BrightSpring Health (BTSG) to $81 from $65 and keeps a Buy rating on the shares. The firm called it its Our Best…
BrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of Directors
LOUISVILLE, Ky., June 12, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “the Company”) (NASDAQ: BTSG), a leading provider of home- and community-based pharmacy and health se...
FTC finalizes order requiring Sevita to divest 128 facilities
The Federal Trade Commission said it has finalized a consent order involving Sevita Health’s acquisition of BrightSpring Health’s (BTSG) community living business. The consent order requires Sevita to...
BrightSpring Health Services Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026
Achieved strong growth above historical targets, driven by specialty pharmacy, LDD wins, and operational efficiencies. Forward strategy focuses on integrated care, expansion in infusion and provider services, and disciplined M&A, with ongoing advocacy to address regulatory headwinds.
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services f...
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services f...